Skip to main content Skip to secondary navigation

Docket #: S19-089

Focused Ultrasound to enhance function and engraftment of pancreatic islets following transplantation

Stanford researchers have demonstrated the application of pulsed Focused Ultrasound (pFUS), to non-invasively enhance the function and engraftment of pancreatic islets following transplantation. Given a significant number of islets are lost immediately after transplantation, pFUS has the potential to be used as a novel therapy to facilitate islet function (i.e. increase insulin secretion) and enhance the engraftment by facilitating islet revascularization and reducing inflammation.

In addition to islet transplantation, this new non-invasive and drug free approach can hold great promise in treating various pancreatic diseases include pancreatitis, pancreatic cancer and diabetes.

Figure

Figure description - Schematic representation of how pFUS can stimulate insulin secretion from ?-cells within pancreatic islets : pFUS enhances insulin secretion by enhancing intracellular calcium levels within ?-cells which then triggers the release of insulin granules via exocytosis.

Stage of Development

  • Animal Studies
  • Continued optimization of ultrasound parameters and applications
  • Applications

    • Islet transplantation for patients with diabetes, pancreatitis, and pancreatic cancer
    • Modulating islet biology within the native pancreas (potentially used in the treatment of pancreatic diseases including diabetes, pancreatitis, pancreatic cancer)

    Advantages

    • Non-invasive and drug-free therapy
    • Applies a new technology (pFUS) to a new area (pancreas)
    • Targeted – does not impact surrounding healthy tissue
    • Focused – can be used to target specific sites within the body
    • Tunable – can use lower or higher dose to control molecular activity in the pancreas

    Publications

    Similar Technologies

    Explore similar technologies by keyword: